$NLS Pharmaceutics (NLSP.US)$ PR Newswire· 3 mins ago NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce the Initial Closing of $500,000 of the Previously Announced $1 Million Fundraising by NLS Following Its Extraordinary General Meeting at a Share Price of $3.10, Representing 48% Above the Market Share Price as of Jan 6, 2025
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more